Digestive Diseases and Sciences

, Volume 60, Issue 7, pp 2038–2048 | Cite as

MicroRNA-370 Attenuates Hepatic Fibrogenesis by Targeting Smoothened

  • Cui-Hua Lu
  • Qian-Ru Hou
  • Long-Fei Deng
  • Chen Fei
  • Wen-Ping Xu
  • Qin Zhang
  • Kai-Ming Wu
  • Bei-Fang Ning
  • Wei-Fen Xie
  • Xin Zhang
Original Article


Background and Aims

Recent research shows that abnormal expression of microRNA plays an important role in the process of hepatic fibrosis . miR-370 has been reported to be involved in liver function and is suppressed during hepatic carcinogenesis. The aim of this study was to investigate the role of miR-370 in hepatic fibrosis.


The expression levels of miR-370 in rat fibrotic livers and activated hepatic stellate cells (HSCs) were evaluated by quantitative real-time PCR. The effect of miR-370 on the activation of HSCs was analyzed by flow cytometric analyses, real-time PCR and Western blot. Adenovirus carrying miR-370 was injected through the tail vein to access the effect of miR-370 on hepatic fibrosis induced by CCl4 in rats. The downstream targets of miR-370 were predicted by the Target Scan database and verified by luciferase assays, real-time PCR and Western blot in HSCs and were further confirmed by immunohistochemistry in vivo.


Real-time PCR showed that miR-370 expression was significantly reduced in rat fibrotic livers and TGFβ1-stimulated HSCs. Overexpression of miR-370 inhibited the proliferation of HSC-T6 cells via inducing cell apoptosis and suppressed the activation of HSCs. Upregulation of miR-370 obviously attenuated the CCl4-induced liver fibrosis in rats. miR-370 was directly bound to the 3′UTR of Smoothened (SMO) and suppressed the expression of SMO in HSCs and fibrotic livers.


Our study demonstrated that miR-370 plays an inhibitory role in hepatic fibrogenesis by targeting SMO. Restoration of miR-370 may have beneficial effects on the treatment of liver fibrosis.


miR-370 Hepatic fibrosis Smoothened Hedgehog signal 



This work was supported by the National Natural Science Foundation of China (81372675), Shanghai Science and Technology Committee for Key Projects (13JC1407401) and Foundation for Talents in Six Fields of Jiangsu Province (no. 2011-WS- 061).

Conflict of interest


Supplementary material

10620_2015_3585_MOESM1_ESM.docx (13 kb)
Supplementary material 1 (DOCX 12 kb)
10620_2015_3585_MOESM2_ESM.docx (331 kb)
Supplementary material 2 (DOCX 330 kb)


  1. 1.
    Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6:425–456.PubMedCrossRefGoogle Scholar
  2. 2.
    Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008;88:125–172.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–233.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Venugopal SK, Jiang J, Kim TH, et al. Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am J Physiol Gastrointest Liver Physiol. 2010;298:G101–G106.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Sekiya Y, Ogawa T, Yoshizato K, Ikeda K, Kawada N. Suppression of hepatic stellate cell activation by microRNA-29b. Biochem Biophys Res Commun. 2011;412:74–79.PubMedCrossRefGoogle Scholar
  6. 6.
    Wang B, Li W, Guo K, Xiao Y, Wang Y, Fan J. miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients. Biochem Biophys Res Commun. 2012;421:4–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Li ZJ, Ou-Yang PH, Han XP. Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells. Cell Signal. 2014;26:141–148.PubMedCrossRefGoogle Scholar
  8. 8.
    Benetatos L, Hatzimichael E, Londin E, et al. The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis. Cell Mol Life Sci. 2013;70:795–814.PubMedCrossRefGoogle Scholar
  9. 9.
    Xu WP, Yi M, Li QQ, et al. Perturbation of MicroRNA-370/Lin-28 homolog A/nuclear factor kappa B regulatory circuit contributes to the development of hepatocellular carcinoma. Hepatology. 2013;58:1977–1991.PubMedCrossRefGoogle Scholar
  10. 10.
    Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol. 2011;25:195–206.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Amakye D, Jagani Z, Dorsch M. Unraveling the therapeutic potential of the Hedgehog pathway in cancer. Nat Med. 2013;19:1410–1422.PubMedCrossRefGoogle Scholar
  12. 12.
    Guy CD, Suzuki A, Zdanowicz M, et al. Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease. Hepatology. 2012;55:1711–1721.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Yang L, Wang Y, Mao H, et al. Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells. J Hepatol. 2008;48:98–106.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Chen Y, Choi SS, Michelotti GA, et al. Hedgehog controls hepatic stellate cell fate by regulating metabolism. Gastroenterology. 2012;143:1319–1329.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Yue HY, Yin C, Hou JL, et al. Hepatocyte nuclear factor 4 alpha attenuates hepatic fibrosis in rats. Gut. 2010;59:236–246.PubMedCrossRefGoogle Scholar
  16. 16.
    Jang JH, Kang KJ, Kim YH, Kang YN, Lee IS. Reevaluation of experimental model of hepatic fibrosis induced by hepatotoxic drugs: an easy, applicable, and reproducible model. Transpl Proc. 2008;40:2700–2703.CrossRefGoogle Scholar
  17. 17.
    Shi R, Chiang VL. Facile means for quantifying microRNA expression by real-time PCR. Biotechniques. 2005;39:519–525.PubMedCrossRefGoogle Scholar
  18. 18.
    Hu PF, Zhu YW, Zhong W, et al. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells. J Gastroenterol Hepatol. 2008;23:1917–1925.PubMedCrossRefGoogle Scholar
  19. 19.
    Meng F, Wehbe-Janek H, Henson R, Smith H, Patel T. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene. 2008;27:378–386.PubMedCrossRefGoogle Scholar
  20. 20.
    Liu J, Xu XF, Yang WJ. The effects of Hedgehog-Gli 1 signaling pathway on proliferation and apoptosis of hepatic stellate cells. Zhonghua Gan Zang Bing Za Zhi. 2009;17:33–37.PubMedGoogle Scholar
  21. 21.
    Lai K, Robertson MJ, Schaffer DV. The sonic hedgehog signaling system as a bistable genetic switch. Biophys J. 2004;86:2748–2757.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Li X, Deng W, Nail CD, et al. Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation. Oncogene. 2006;25:609–621.PubMedCentralPubMedGoogle Scholar
  23. 23.
    He Y, Huang C, Zhang SP, Sun X, Long XR, Li J. The potential of microRNAs in liver fibrosis. Cell Signal. 2012;24:2268–2272.PubMedCrossRefGoogle Scholar
  24. 24.
    Iliopoulos D, Drosatos K, Hiyama Y, Goldberg IJ, Zannis VI. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res. 2010;51:1513–1523.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Qi L, Hongjuan H, Ning G, et al. miR-370 is stage-specifically expressed during mouse embryonic development and regulates Dnmt3a. FEBS Lett. 2013;587:775–781.PubMedCrossRefGoogle Scholar
  26. 26.
    Li L, Li G, Yu C, et al. A role of microRNA-370 in hepatic ischaemia-reperfusion injury by targeting transforming growth factor-beta receptor II. Liver Int. 2014. doi: 10.1111/liv.12441.
  27. 27.
    An F, Yamanaka S, Allen S, et al. Silencing of miR-370 in human cholangiocarcinoma by allelic loss and interleukin-6 induced maternal to paternal epigenotype switch. PLoS ONE. 2012;7:e45606.PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Cao X, Liu D, Yan X, et al. Stat3 inhibits WTX expression through up-regulation of microRNA-370 in Wilms tumor. FEBS Lett. 2013;587:639–644.PubMedCrossRefGoogle Scholar
  29. 29.
    Chang KW, Chu TH, Gong NR, et al. miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma. Oral Dis. 2013;19:611–619.PubMedCrossRefGoogle Scholar
  30. 30.
    Itoh T, Ando M, Tsukamasa Y, Akao Y. Expression of BMP-2 and Ets1 in BMP-2-stimulated mouse pre-osteoblast differentiation is regulated by microRNA-370. FEBS Lett. 2012;586:1693–1701.PubMedCrossRefGoogle Scholar
  31. 31.
    Lo SS, Hung PS, Chen JH, et al. Overexpression of miR-370 and downregulation of its novel target TGFbeta-RII contribute to the progression of gastric carcinoma. Oncogene. 2012;31:226–237.PubMedCrossRefGoogle Scholar
  32. 32.
    Wu Z, Sun H, Zeng W, He J, Mao X. Upregulation of MircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1. PLoS ONE. 2012;7:e45825.PubMedCentralPubMedCrossRefGoogle Scholar
  33. 33.
    Zhang X, Zeng J, Zhou M, et al. The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia. Mol Cancer. 2012;11:56.PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Garcia-Orti L, Cristobal I, Cirauqui C, et al. Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemia. PLoS ONE. 2012;7:e47717.PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    Sicklick JK, Li YX, Choi SS, et al. Role for hedgehog signaling in hepatic stellate cell activation and viability. Lab Invest. 2005;85:1368–1380.PubMedCrossRefGoogle Scholar
  36. 36.
    Stewart GA, Hoyne GF, Ahmad SA, et al. Expression of the developmental Sonic hedgehog (Shh) signalling pathway is up-regulated in chronic lung fibrosis and the Shh receptor patched 1 is present in circulating T lymphocytes. J Pathol. 2003;199:488–495.PubMedCrossRefGoogle Scholar
  37. 37.
    Fabian SL, Penchev RR, St-Jacques B, et al. Hedgehog-Gli pathway activation during kidney fibrosis. Am J Pathol. 2012;180:1441–1453.PubMedCentralPubMedCrossRefGoogle Scholar
  38. 38.
    Jung IH, Jung DE, Park YN, Song SY, Park SW. Aberrant Hedgehog ligands induce progressive pancreatic fibrosis by paracrine activation of myofibroblasts and ductular cells in transgenic zebrafish. PLoS ONE. 2011;6:e27941.PubMedCentralPubMedCrossRefGoogle Scholar
  39. 39.
    Horn A, Palumbo K, Cordazzo C, et al. Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis. Arthritis Rheum. 2012;64:2724–2733.PubMedCrossRefGoogle Scholar
  40. 40.
    Omenetti A, Choi S, Michelotti G, Diehl AM. Hedgehog signaling in the liver. J Hepatol. 2011;54:366–373.PubMedCentralPubMedCrossRefGoogle Scholar
  41. 41.
    Nagase T, Nagase M, Machida M, Yamagishi M. Hedgehog signaling: a biophysical or biomechanical modulator in embryonic development? Ann N Y Acad Sci. 2007;1101:412–438.PubMedCrossRefGoogle Scholar
  42. 42.
    Scarpa M, Grillo AR, Brun P, et al. Snail1 transcription factor is a critical mediator of hepatic stellate cell activation following hepatic injury. Am J Physiol Gastrointest Liver Physiol. 2011;300:G316–G326.PubMedCrossRefGoogle Scholar
  43. 43.
    Michelotti GA, Xie G, Swiderska M, et al. Smoothened is a master regulator of adult liver repair. J Clin Invest. 2013;123:2380–2394.PubMedCentralPubMedGoogle Scholar
  44. 44.
    Philips GM, Chan IS, Swiderska M, et al. Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer. PLoS ONE. 2011;6:e23943.PubMedCentralPubMedCrossRefGoogle Scholar
  45. 45.
    Swiderska-Syn M, Syn WK, Xie G, et al. Myofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy. Gut. 2014;63:1333–1344.PubMedCrossRefGoogle Scholar
  46. 46.
    Pratap A, Singh S, Mundra V, et al. Attenuation of early liver fibrosis by pharmacological inhibition of smoothened receptor signaling. J Drug Target. 2012;20:770–782.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Cui-Hua Lu
    • 1
  • Qian-Ru Hou
    • 1
  • Long-Fei Deng
    • 2
  • Chen Fei
    • 2
  • Wen-Ping Xu
    • 2
  • Qin Zhang
    • 2
  • Kai-Ming Wu
    • 2
  • Bei-Fang Ning
    • 2
  • Wei-Fen Xie
    • 2
  • Xin Zhang
    • 2
  1. 1.Department of Gastroenterology, Affiliated Hospital of Nantong UniversityMedical College of Nantong UniversityNantongChina
  2. 2.Department of Gastroenterology, Changzheng HospitalSecond Military Medical UniversityShanghaiChina

Personalised recommendations